잠시만 기다려 주세요. 로딩중입니다.

SARS-CoV-2 Infection of Airway Epithelial Cells

Immune Network 2021년 21권 1호 p.3 ~ 3
류광희, 신현우,
소속 상세정보
류광희 ( Ryu Gwang-Hui ) - Soonchunhyang University College of Medicine Department of Otorhinolaryngology-Head and Neck Surgery
신현우 ( Shin Hyun-Woo ) - Seoul National University College of Medicine Department of Pharmacology

Abstract


Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide since its outbreak in December 2019, and World Health Organization declared it as a pandemic on March 11, 2020. SARS-CoV-2 is highly contagious and is transmitted through airway epithelial cells as the first gateway. SARS-CoV-2 is detected by nasopharyngeal or oropharyngeal swab samples, and the viral load is significantly high in the upper respiratory tract. The host cellular receptors in airway epithelial cells, including angiotensin-converting enzyme 2 and transmembrane serine protease 2, have been identified by single-cell RNA sequencing or immunostaining. The expression levels of these molecules vary by type, function, and location of airway epithelial cells, such as ciliated cells, secretory cells, olfactory epithelial cells, and alveolar epithelial cells, as well as differ from host to host depending on age, sex, or comorbid diseases. Infected airway epithelial cells by SARS-CoV-2 in ex vivo experiments produce chemokines and cytokines to recruit inflammatory cells to target organs. Same as other viral infections, IFN signaling is a critical pathway for host defense. Various studies are underway to confirm the pathophysiological mechanisms of SARS-CoV-2 infection. Herein, we review cellular entry, host-viral interactions, immune responses to SARS-CoV-2 in airway epithelial cells. We also discuss therapeutic options related to epithelial immune reactions to SARS-CoV-2.

키워드

COVID-19; Coronavirus; SARS-CoV-2; Respiratory system; Epithelial cells

원문 및 링크아웃 정보

 

등재저널 정보